📄 JAMA Clinical Guidelines Synopsis: The 2025 Infectious Diseases Society of America guideline recommends nirmatrelvir-ritonavir or intravenous remdesivir for adults with mild to moderate #COVID19 who are at high risk for progression to severe #disease. ja.ma/4eQEUjb

3 likes 1 replies